Article Details

Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD US Commercialisation and ...

Retrieved on: 2024-03-17 22:43:11

Tags for this article:

Click the tags to see associated articles and topics

Proteomics International Laboratories Ltd (ASX:PIQ) PromarkerD US Commercialisation and .... View article details on HISWAI: http://www.abnnewswire.net/press/en/124216/Proteomics-International-Laboratories-Ltd-(ASX-PIQ)-PromarkerD-US-Commercialisation-and-Promarker-Pipeline-Update.html

Summary

The article discusses Proteomics International Laboratories Ltd's efforts to commercialize PromarkerD in the U.S. for diabetic kidney disease and other diagnostic tests, highlighting the field of biotech, which encompasses genomics, omics, and proteomics.

Article found on: www.abnnewswire.net

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up